ALEMBICLTDConsumer Discretionary

Alembic Limited

Residential, Commercial Projects · ISIN INE426A01027 · BSE 506235 · NSE EQ · FV ₹2
Last price
₹103
+3.81%today
What this company does

Alembic Limited operates in Residential, Commercial Projects, part of the Consumer Discretionary sector. It booked ₹49 cr of revenue in its latest quarter (Q1 FY27) and kept 133.1% of sales as profit.

In the report:
66out of 100
Equitytale Health Score
Solid

Healthier than 66% of companies in Consumer Discretionary, on all six measures of filed financials. Each measure is ranked against the 63–421 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
55

At close. Not part of the score.

Profitability & returns55

How much profit it earns on the money it employs

Balance sheet84

How much it owes, and whether earnings cover the interest

Cash quality54

Whether reported profit actually arrives as cash

Growth & consistency78

Whether sales and profit have grown, and how steadily

Valuation40

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Is this company doing well?
not investment advice
Strengths
Makes a profit
Strong 133% net margin
Profit up 5% vs last year
Promoters hold 71%
No promoter shares pledged
Virtually debt-free
Turns profit into real cash
Watch-outs
None flagged from our data

What if I invest in ALEMBICLTD?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 15% a year, it would become
₹26.30 lakh

The slider starts at 15%, taken from this company's own free-cash-flow trend. That is history, not a forecast — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹103 +3.81%
latest close · 2026-09-17
1-year return
-0.8%
52-wk low ₹5752-wk high ₹125
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio10.2Low
LowAverageHigh
P/B ratio1.08Moderate
Below bookModerateHigh
EV / EBITDA30.9High
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity10.6%Fair
WeakFairStrong ▸15%
Return on capital2.9%Weak
WeakFairStrong
Net margin133.1%Strong
ThinDecentStrong
EBITDA margin43.9%Healthy
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.00Comfortable
LowModerateHigh ▸1
Interest cover29.7×Strong
RiskyOkayStrong ▸5×
Current ratio1.95Healthy
Tight ◂1HealthyAmple
More figures
Market cap
₹2,638 cr
Book value
₹95
EPS
₹2.53
latest quarter
Net debt
₹9 cr
owes more than its cash
Enterprise value
₹2,647 cr
EBITDA
₹86 cr
annualised
EBIT
₹72 cr
annualised
Operating margin
36.8%
Return on assets
10.0%
Earnings yield
9.85%
P/S
13.53
Sales / share
₹7.6
Tax rate
9.5%
Face value
₹2
Shares
25.7 cr
Working capital
₹96 cr
Current assets
₹197 cr
Current liabilities
₹101 cr
Delivery %
40.8%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2026 report & filings
not investment advice
Looks overpricedMedium confidence
Median of 2 models ₹62 vs market price ₹103 — price is 67% above it
Safety cushion-66.9%(target ≥ +20%)
Models span ₹50₹73, midpoint ₹62
Model ₹62
Price ₹103
Cheap sideExpensive side

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹49 cr
Other Income₹6 cr
Total Income₹55 cr
Cost of Materials₹5 cr
Purchases of Stock-in-Trade₹0 cr
Inventory Change (±)₹-51.5 L
Employee Benefit Expense₹10 cr
Finance Costs₹60.5 L
Depreciation & Amortisation₹3 cr
Other Expenses₹18 cr
Total Expenses₹37 cr
Profit before Tax₹17 cr
Tax Expense₹2 cr
Share of JV / Associates₹49 cr
Net Profit₹65 cr
Net margin on total income118.6%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹4 cr4.2%
Employee benefit expense₹10 cr10.1%
Finance costs₹60.5 L0.6%
Depreciation & amortisation₹3 cr3.3%
Other expenses₹18 cr17.7%
Tax expense₹2 cr1.6%
Profit for the period₹65 cr62.5%
Total income ₹55 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue74 cr60 cr49 cr
Total income77 cr62 cr55 cr
Expenses51 cr44 cr37 cr
Profit before tax26 cr18 cr17 cr
Tax3 cr9 cr2 cr
Net profit (owners' share)60 cr-34 cr65 cr
Net margin (owners' share, on revenue)80.9%-56.4%133.1%
EPS (₹)2.342.612.53
YoY (latest quarter): total income +2.6% · net profit +5.3%
Balance sheet & cash flow · as of Mar 2026
Debt-free
Total assets
₹2,590 cr
Shareholder equity
₹2,445 cr
parent shareholders
Total debt
₹11 cr
Cash
₹1 cr
Cash flow · H1 FY26
Operating
₹50 cr
Investing
₹13 cr
Financing
₹-64 cr
Peer comparison
Residential, Commercial Projects · by market value
CompanyPriceMarket capP/E
DLF Limited₹640₹1.58 L cr49.8
Lodha Developers Limited₹1,103₹1.10 L cr20.1
The Phoenix Mills Limited₹1,872₹66,957 cr56.4
Oberoi Realty Limited₹1,741₹63,292 cr29.1
Prestige Estates Projects Limited₹1,440₹62,025 cr65.7
Godrej Properties Limited₹1,678₹50,551 cr36.1
Anant Raj Limited₹597₹21,482 cr35.9
Brigade Enterprises Limited₹621₹20,251 cr25.3
Horizon Industrial Parks Limited₹52₹12,779 cr
Same industry · latest reported numbers · not a recommendation.
Corporate actions
Dividend yield
2.34%
trailing 12 months
Dividend / share (TTM)
₹2.4
Last dividend
₹2.4
ex 4 Aug 2026
ActionDetailEx-date
Dividend₹2.4 / share4 Aug 2026
Dividend₹2.4 / share5 Aug 2025
Dividend₹2.4 / share5 Aug 2024
Dividend₹2.2 / share3 Aug 2023
Dividend₹1.8 / share12 Sep 2022
Dividend₹0.2 / share29 Jul 2021
Who owns it · 2026-06-30
No pledge
Promoter
70.9%
FII / Foreign
1.3%
DII / Domestic
0.1%
Retail / others
27.8%
Smart-money activity
Insider trades
BoughtNirayu Private Limited · Promoter Group9,495 · ₹9.4 L2 Sep 26
BoughtNirayu Private Limited · Promoter Group9,495 · ₹9.4 L2 Sep 26
BoughtNirayu Private Limited · Promoter Group2.17 L · ₹2.1 cr31 Aug 26
Bulk / block deals
SoldNK SECURITIES RESEARCH PRIVATE LIMITED · NSE14.46 L @ ₹113.153 Sep 26
BoughtNK SECURITIES RESEARCH PRIVATE LIMITED · NSE14.46 L @ ₹113.113 Sep 26
SoldMICROCURVES TRADING PRIVATE LIMITED · NSE18.66 L @ ₹113.993 Sep 26
Stake changes
SoldSBI Mutual Fund under its Various Schemes→ 2.72% · 10.00 L11 Oct 23
BoughtPranav Chirayu Amin alongwith PAC · promoter→ 64.52%2 Jan 20
SoldMalika Chirayu Amin · promoter→ 67.09%2 Jan 20
What shareholders were asked to approve
2 proposals passed only on promoter votes

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 11 Aug 2026
See the official result
1
To receive, consider and adopt: a. the Audited Standalone Financial Statements of the Company for the financial year ended 31st March, 2026 together with the Reports of the Board of Directors and the Auditors thereon. b. the Audited Consolidated Financial Statements of the Company for the financial year ended 31st March, 2026 together with the Report of the Auditors thereon.
Backed by 100% of shareholders other than promotersneeded 50%
85.11 L votes for, 5,251 against · 0% of mutual funds and other big investors said no
2
To declare dividend on equity shares for the financial year 2025-26.
Backed by 100% of shareholders other than promotersneeded 50%
85.85 L votes for, 5,387 against · 0% of mutual funds and other big investors said no
3
To appoint a Director in place of Mrs. Malika Amin (DIN: 00242613), who retires by rotation and being eligible, offers herself for re-appointment.
Backed by 100% of shareholders other than promotersneeded 50%
85.77 L votes for, 12,704 against · 0% of mutual funds and other big investors said no
4
Payment of commission to Mr. Udit Amin (DIN: 00244235) for the period upto 30th September, 2025, as Non-Executive Director of the Company.
⚑ Passed only because promoters voted yes
Backed by 73% of shareholders other than promotersneeded 75%
63.12 L votes for, 22.78 L against · 100% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 34 named members
owning 70.9% between them · as of 2026-06-30
Nirayu Private Limited63.06%
Chirayu Ramanbhai Amin3.24%
Malika Chirayu Amin2.99%
Pranav Chirayu Amin0.75%
Shaunak Chirayu Amin0.75%
Inaaya Shaunak Amin0.02%
Naintara Shaunak Amin0.02%
Ranvir Pranav Amin0.02%
Business done with them
FY2026 · 9 of the group
The company paid ₹52 cr to companies in the promoter group last year — about 21.7% of its ₹240 cr revenue and received ₹114 cr back from them.
ALEMBIC PHARMACEUTICALS LIMITED
Other income from them · As mentioned below
₹63 cr
company received
NIRAYU PRIVATE LIMITED
Other payments to them · As mentioned below
also owns 63.06% of the company
₹39 cr
company paid
ALEMBIC PHARMACEUTICALS LIMITED
Provided services to them · As mentioned below
₹32 cr
company received
ALEMBIC PHARMACEUTICALS LIMITED
Leases As Lessor · As mentioned below
₹13 cr
company received
ALEMBIC PHARMACEUTICALS LIMITED
Sold goods to them · As mentioned below
₹12 cr
company received
SHRENO LIMITED
Provided services to them · As mentioned below
₹6 cr
company received
ALEMBIC PHARMACEUTICALS LIMITED
Other payments to them · As mentioned below
₹5 cr
company paid
UDIT CHIRAYU AMIN
Other payments to them · As mentioned below
₹2 cr
company paid
CHIRAYU RAMANBHAI AMIN
Other payments to them · As mentioned below
also owns 3.24% of the company
₹2 cr
company paid
MALIKA CHIRAYU AMIN
Other payments to them · As mentioned below
also owns 2.99% of the company
₹2 cr
company paid
PAUSHAK LIMITED
Other income from them · As mentioned below
₹2 cr
company received
SHRENO PUBLICATIONS LIMITED
Leases As Lessor · As mentioned below
₹94.3 L
company received
SHRENO ENGINEERING LIMITED
Bought goods from them · As mentioned below
₹92.6 L
company paid
NIRAYU PRIVATE LIMITED
Paid them for services · As mentioned below
also owns 63.06% of the company
₹80.6 L
company paid
PAUSHAK LIMITED
Provided services to them · As mentioned below
₹59 L
company received
PAUSHAK LIMITED
Leases As Lessor · As mentioned below
₹49.7 L
company received
ALEMBIC PHARMACEUTICALS LIMITED
Bought goods from them · As mentioned below
₹30.6 L
company paid
PAUSHAK LIMITED
Bought goods from them · As mentioned below
₹26.2 L
company paid
SHRENO ENGINEERING LIMITED
Leases As Lessor · As mentioned below
₹15.2 L
company received
PAUSHAK LIMITED
Other payments to them · As mentioned below
₹6.6 L
company paid
SHRENO ENGINEERING LIMITED
Contribution received from them · As mentioned below
₹4.4 L
company received
SHRENO ENGINEERING LIMITED
Other payments to them · As mentioned below
₹1.5 L
company paid
NIRAYU PRIVATE LIMITED
Leases As Lessor · As mentioned below
also owns 63.06% of the company
₹0.57 L
company received
SHRENO LIMITED
Bought goods from them · As mentioned below
₹0.18 L
company paid
SHRENO PUBLICATIONS LIMITED
Bought goods from them · As mentioned below
₹0.11 L
company paid
PAUSHAK LIMITED
Sold property or assets to them · As mentioned below
₹0.07 L
company received

The company also transacted with 7 other related parties — subsidiaries, joint ventures, directors and others — that we could not match by name to the promoter list above. Some may still be connected to the family; we only count the ones the filings let us match with certainty.

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.